Home » Newsletters » BioWorld Science

BioWorld Science

April 17, 2020

View Archived Issues

Multiple drivers explained

Machine learning-based predictive model identifies CLL patients at risk of infection or treatment

PLEK2 is involved in NSCLC migration and vascular invasion during metastasis

Evotec and leon-nanodrugs enter strategic partnership

FDA approves IND to initiate phase II study of KN-046 in NSCLC in U.S.

FairJourney and Iontas collaborate in search for SARS-CoV-2 therapy

FDA accepts IND application for AUTO-1 for adult ALL

Targeting CPT1A leads to significant inhibition of HGSOC progression

AS-48 shows promising activity in mouse models of Chagas' disease

GSK-3527497: an orally available TRPV4 antagonist for heart failure-induced pulmonary edema

Shanghai Longwood Biopharmaceuticals presents TP53/MDM2 interaction inhibitors

New ataxia telangiectasia mutated kinase inhibitors described by Medshine Discovery

Rudong Ringene Pharmaceuticals discovers BRD inhibitors

New RET inhibitors identified at Applied Pharmaceutical Science

Sunshine Lake Pharma discovers HBV HBsAg secretion inhibitors

CNI-103: a potent calcineurin/NFAT interaction peptidyl inhibitor against sepsis-induced ALI

Making neurons from glia alleviates neurodegenerative diseases

Nested phase-change contrast agent Electrast activated by depolarizing myocardium

LegoChem establishes oncology research collaboration and license agreement with Iksuda

Amgen studies AMG-650 in phase I trial for advanced solid tumors

CanSino begins phase Ia study of protein-based pneumococcal vaccine

Liverpool University to study Dilafor's tafoxiparin for COVID-19

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...